Both in Pharmaceuticals
Dermata Therapeutics vs Onconetix
Over the past year DRMA returned −77.4% and ONCO returned −99.7%; their daily moves had a correlation of 0.06.
DRMA −77.4% ONCO −99.7%Growth of $1, one year, split-adjusted
| Metric | DRMA | ONCO |
|---|---|---|
| Price | $0.7750 | $0.5610 |
| Market cap | $3.8M | $3.3M |
| Today | −7.86% | −4.27% |
| 1 month | −30.2% | −24.6% |
| 6 months | −41.7% | −91.2% |
| Year to date | −66.6% | −99.3% |
| 1 year | −79.1% | −99.7% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | — | 25.1% |
| Net margin | — | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.1× |
| Net cash | $4.4M | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 129.8% | 157.0% |
| Short % of float | 2.5% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).